Literature DB >> 22974802

Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.

François-Pierre Mongeon1, Michael Jerosch-Herold, Otávio Rizzi Coelho-Filho, Ron Blankstein, Rodney H Falk, Raymond Y Kwong.   

Abstract

OBJECTIVES: The aim of this study was to perform direct quantification of myocardial extracellular volume fraction (ECF) with T1-weighted cardiac magnetic resonance (CMR) imaging in patients suspected to have infiltrative heart disease.
BACKGROUND: Infiltrative heart disease refers to accumulation of abnormal substances within the myocardium. Qualitative assessment of late gadolinium enhancement (LGE) remains the most commonly used method for CMR evaluation of patients suspected with myocardial infiltration. This technique is widely available and can be performed in a reproducible and standardized manner. However, the degree of extracellular matrix expansion due to myocardial infiltration in the intercellular space has, to date, not been amenable to noninvasive quantification with LGE.
METHODS: We performed 3-T CMR in 38 patients (mean age 68 ± 15 years) who were referred for assessment of infiltrative heart disease and also in 9 healthy volunteers as control subjects. The T1 quantification by Look-Locker gradient-echo before and after contrast determined segmental myocardial partition coefficients. The ECF was obtained by referencing the tissue partition coefficient for gadolinium to the plasma volume fraction in blood, derived from serum hematocrit. Cine CMR and LGE imaging in matching locations were also performed.
RESULTS: Seventeen patients (45%) had cardiac amyloidosis (CA) (biopsy-confirmed or clinically highly probable), 20 (53%) had a non-amyloid cardiomyopathy, and 1 had lysosomal storage disease. Median global ECF was substantially higher in CA patients (0.49) compared with non-amyloid cardiomyopathy patients (0.33, p < 0.0001) and volunteers (0.24, p = 0.0001). The ECF strongly correlated with visually assessed segmental LGE (r = 0.80, p < 0.0001) and LV mass index (r = 0.69, p < 0.0001), reflecting severity of myocardial infiltration. In patients with CA, ECF was highest in segments with LGE, although it remained elevated in segments without qualitative LGE.
CONCLUSIONS: The CMR ECF quantification identified substantial expansion of the interstitial space in patients with CA compared with volunteers. Further studies using this technique for diagnosis and assessment of the severity of myocardial infiltration are warranted.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22974802      PMCID: PMC3954504          DOI: 10.1016/j.jcmg.2012.04.006

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  28 in total

Review 1.  The role of cardiovascular magnetic resonance imaging in heart failure.

Authors:  Theodoros D Karamitsos; Jane M Francis; Saul Myerson; Joseph B Selvanayagam; Stefan Neubauer
Journal:  J Am Coll Cardiol       Date:  2009-10-06       Impact factor: 24.094

2.  Feasibility of the single-bolus strategy for measuring the partition coefficient of Gd-DTPA in patients with myocardial infarction: independence of image delay time and maturity of scar.

Authors:  Rebecca E Thornhill; Frank S Prato; Gerald Wisenberg; James A White; Judith Nowell; Anya Sauer
Journal:  Magn Reson Med       Date:  2006-04       Impact factor: 4.668

3.  Determining the extent to which delayed-enhancement images reflect the partition-coefficient of Gd-DTPA in canine studies of reperfused and unreperfused myocardial infarction.

Authors:  Rebecca E Thornhill; Frank S Prato; Gerald Wisenberg; Gerald R Moran; Jane Sykes
Journal:  Magn Reson Med       Date:  2004-11       Impact factor: 4.668

4.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

5.  Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.

Authors:  Imran S Syed; James F Glockner; Dali Feng; Philip A Araoz; Matthew W Martinez; William D Edwards; Morie A Gertz; Angela Dispenzieri; Jae K Oh; Diego Bellavia; A Jamil Tajik; Martha Grogan
Journal:  JACC Cardiovasc Imaging       Date:  2010-02

6.  Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy.

Authors:  Francesco De Cobelli; Antonio Esposito; Elena Belloni; Maurizio Pieroni; Gianluca Perseghin; Cristina Chimenti; Andrea Frustaci; Alessandro Del Maschio
Journal:  AJR Am J Roentgenol       Date:  2009-03       Impact factor: 3.959

7.  Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography.

Authors:  Jong-Won Ha; Steve R Ommen; A Jamil Tajik; Marion E Barnes; Naser M Ammash; Morie A Gertz; James B Seward; Jae K Oh
Journal:  Am J Cardiol       Date:  2004-08-01       Impact factor: 2.778

8.  Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation.

Authors:  J D Carroll; W H Gaasch; K P McAdam
Journal:  Am J Cardiol       Date:  1982-01       Impact factor: 2.778

9.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.

Authors:  Leah Iles; Heinz Pfluger; Arintaya Phrommintikul; Joshi Cherayath; Pelin Aksit; Sandeep N Gupta; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

10.  Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis.

Authors:  Alicia M Maceira; Sanjay K Prasad; Philip N Hawkins; Michael Roughton; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2008-11-25       Impact factor: 5.364

View more
  57 in total

Review 1.  Recent Advances in Cardiovascular Magnetic Resonance: Techniques and Applications.

Authors:  Michael Salerno; Behzad Sharif; Håkan Arheden; Andreas Kumar; Leon Axel; Debiao Li; Stefan Neubauer
Journal:  Circ Cardiovasc Imaging       Date:  2017-06       Impact factor: 7.792

Review 2.  Role of Imaging in Evaluating Infiltrative Heart Disease.

Authors:  Sanjay Divakaran; Avinainder Singh; Bradley Collins; Tomas Vita; Rodney H Falk; Marcelo F Di Carli; Ron Blankstein
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

3.  Accurate analysis and visualization of cardiac (11)C-PIB uptake in amyloidosis with semiautomatic software.

Authors:  Tanja Kero; Lars Lindsjö; Jens Sörensen; Mark Lubberink
Journal:  J Nucl Cardiol       Date:  2015-07-15       Impact factor: 5.952

Review 4.  Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.

Authors:  Omar K Siddiqi; Frederick L Ruberg
Journal:  Trends Cardiovasc Med       Date:  2017-07-13       Impact factor: 6.677

5.  Quantitative molecular imaging of cardiac amyloidosis: The journey has begun.

Authors:  Sharmila Dorbala; Marie Foley Kijewski; Mi-Ae Park
Journal:  J Nucl Cardiol       Date:  2015-07-16       Impact factor: 5.952

Review 6.  Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies.

Authors:  Maythem Saeed; Steven W Hetts; Robert Jablonowski; Mark W Wilson
Journal:  World J Cardiol       Date:  2014-11-26

7.  Point estimate and reference normality interval of MRI-derived myocardial extracellular volume in healthy subjects: a systematic review and meta-analysis.

Authors:  Francesco Sardanelli; Simone Schiaffino; Moreno Zanardo; Francesco Secchi; Paola Maria Cannaò; Federico Ambrogi; Giovanni Di Leo
Journal:  Eur Radiol       Date:  2019-05-02       Impact factor: 5.315

8.  Cardiovascular magnetic resonance myocardial T1 mapping to detect and quantify cardiac involvement in familial amyloid polyneuropathy.

Authors:  Seitaro Oda; Daisuke Utsunomiya; Kosuke Morita; Takeshi Nakaura; Hideaki Yuki; Masafumi Kidoh; Kenichiro Hirata; Narumi Taguchi; Noriko Tsuda; Shinya Shiraishi; Tomohiro Namimoto; Kyoko Hirakawa; Seiji Takashio; Yasuhiro Izumiya; Megumi Yamamuro; Seiji Hokimoto; Kenichi Tsujita; Mitsuharu Ueda; Taro Yamashita; Yukio Ando; Yasuyuki Yamashita
Journal:  Eur Radiol       Date:  2017-05-05       Impact factor: 5.315

9.  Comparison of quantitative imaging parameters using cardiovascular magnetic resonance between cardiac amyloidosis and hypertrophic cardiomyopathy: inversion time scout versus T1 mapping.

Authors:  Bo Da Nam; Sung Mok Kim; Hye Na Jung; Yiseul Kim; Yeon Hyeon Choe
Journal:  Int J Cardiovasc Imaging       Date:  2018-05-30       Impact factor: 2.357

10.  Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy.

Authors:  Tomas G Neilan; Otavio R Coelho-Filho; Ravi V Shah; Jiazuo H Feng; Diego Pena-Herrera; Damien Mandry; Francois Pierre-Mongeon; Bobak Heydari; Sanjeev A Francis; Javid Moslehi; Raymond Y Kwong; Michael Jerosch-Herold
Journal:  Am J Cardiol       Date:  2012-12-08       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.